Avanir Pharmaceuticals, Inc. (AVNR) Posts Q3 EPS Loss of $0.13, Revenues Fall Inline

Go back to Avanir Pharmaceuticals, Inc. (AVNR) Posts Q3 EPS Loss of $0.13, Revenues Fall Inline